Franklin Resources
RLAY icon

Franklin Resources’s Relay Therapeutics RLAY Stock Holding History

Franklin Resources’s Portfolio RLAY Stock Details RLAY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$34.7M Buy
1,856,913
+1,807,998
+3,696% +$26.2M 0.01% 798
2026
Q1 		$487K Hold
48,915
– – ﹤0.01% 2469
2025
Q4 		$414K Sell
48,915
-330,448
-87% -$2.36M ﹤0.01% 2486
2025
Q3 		$1.98M Sell
379,363
-14,759
-4% -$56.3K ﹤0.01% 1774
2025
Q2 		$1.36M Buy
394,122
+223,042
+130% +$663K ﹤0.01% 1854
2025
Q1 		$448K Buy
171,080
+112,275
+191% +$440K ﹤0.01% 2310
2024
Q4 		$242K Sell
58,805
-1,338,037
-96% -$7.28M ﹤0.01% 2591
2024
Q3 		$9.43M Buy
1,396,842
+1,361,779
+3,884% +$10.2M ﹤0.01% 1150
2024
Q2 		$229K Buy
35,063
+5,176
+17% +$35.4K ﹤0.01% 2527
2024
Q1 		$248K Sell
29,887
-24
-0.1% -$234 ﹤0.01% 2523
2023
Q4 		$329K Buy
+29,911
New +$252K ﹤0.01% 2130

Other funds holding RLAY

SIAU
SB Investment Advisers (UK) London, United Kingdom $7.66B AUM 20.12% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
CC
Casdin Capital New York $2B AUM 147.21% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
CC
Commodore Capital New York $1.68B AUM 375.52% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
NI
Nextech Invest Zurich, Switzerland $2.11B AUM 413.84% 1-Year Est. Return

Franklin Resources's RLAY Position: Q2 2026 in Review

Franklin Resources increased its Relay Therapeutics (RLAY) stake by 3,696% in Q2 2026, buying an estimated $26.2M and bringing the position to 1,856,913 shares worth $34.7M. The position accounts for 0.01% of the portfolio, ranked #798.

Franklin Resources first reported a position in RLAY in Q4 2023 and has held it in 11 quarters since. 258 funds tracked by Wall St. Rank hold RLAY as of Q2 2026.

  • Franklin Resources held 1,856,913 shares of Relay Therapeutics worth $34.7M as of Q2 2026.
  • Franklin Resources bought 1,807,998 Relay Therapeutics shares in Q2 2026, an estimated $26.2M.
  • Relay Therapeutics made up 0.01% of Franklin Resources's portfolio in Q2 2026, its #798 holding.
  • Franklin Resources first reported a position in Relay Therapeutics in Q4 2023 and has held it in 11 quarters since.
  • 258 funds tracked by Wall St. Rank held Relay Therapeutics as of Q2 2026.

Based on Franklin Resources's 13F filing for Q2 2026, filed 13 Aug 2026.